BRIEF published on 07/03/2026 at 21:15, 2 months 9 days ago End of Talks Between Exail Technologies and Safran Exclusive Negotiations Exail Technologies Defense Sector Autonomous Robotics Safran Acquisition
BRIEF published on 07/03/2026 at 21:15, 2 months 9 days ago Fin des discussions entre Exail Technologies et Safran Stratégie Safran Acquisition Defense Exail Technologies
BRIEF published on 07/03/2026 at 21:15, 2 months 9 days ago Discussions between Exail Technologies and Safran have ended. Acquisition Strategy Defense Exail Technologies Saffron
BRIEF published on 07/03/2026 at 21:15, 2 months 9 days ago Fin des négociations entre Exail Technologies et Safran Négociations Exclusives Exail Technologies Robotique Autonome Secteur De La Défense Acquisition De Safran
PRESS RELEASE published on 07/03/2026 at 21:10, 2 months 9 days ago Fin des discussions entre Exail Technologies et Safran Exail Technologies met fin aux négociations exclusives avec Safran concernant une éventuelle acquisition. La société se recentre sur sa stratégie et son développement, spécialisée en défense de haute technologie Acquisition Négociations Exclusives Defense Exail Technologies Haute Technologie
PRESS RELEASE published on 07/03/2026 at 21:10, 2 months 9 days ago End of discussions between Exail Technologies and Safran Exail Technologies confirms the end of acquisition discussions with Safran. Focus remains on long-term development strategies for shareholders, customers, and employees Safran Acquisition Strategy Negotiations Exail Technologies
BRIEF published on 06/26/2026 at 14:40, 2 months 16 days ago Exail Technologies in negotiations with Safran for a possible acquisition Acquisition Negotiations Public Offering Exail Technologies Saffron
BRIEF published on 06/26/2026 at 14:40, 2 months 16 days ago Exail Technologies en négociations avec Safran pour une éventuelle acquisition Safran Acquisition Négociations Offre Publique Exail Technologies
PRESS RELEASE published on 06/26/2026 at 14:35, 2 months 16 days ago Information concernant des négociations entre Exail Technologies et Safran Exail Technologies en discussions pour acquisition par Safran. Prix de 128,5 euros par action. Aucune certitude sur aboutissement Safran Acquisition Négociations Exail Technologies 128,5 Euros
BRIEF published on 06/11/2026 at 18:00, 3 months 1 day ago Exail Technologies en négociations pour refinancer sa filiale Exail Holding Liquidité Refinancement Exail Technologies Évaluation ICG
Published on 09/12/2026 at 02:35, 1 day 10 hours ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 1 day 14 hours ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 21:25, 1 day 15 hours ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 1 day 20 hours ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 17:50, 19 hours 22 minutes ago New Delhi Marks UN Day for South-South Cooperation with Push to Scale Dryland Innovation Across the Global South
Published on 09/12/2026 at 07:30, 1 day 5 hours ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 1 day 14 hours ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 1 day 15 hours ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 1 day 17 hours ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 07:00, 2 days 6 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 2 days 6 hours ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 2 days 17 hours ago Availability of the 2026 Interim Financial Report
